Selected research
Industry Growth & Trends
Global HPV Therapeutic Vaccines Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global HPV Therapeutic Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for HPV Therapeutic Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for HPV Therapeutic Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for HPV Therapeutic Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the HPV Therapeutic Vaccines market include Shanghai Bovax Biotechnology Co., Ltd., Sanofi Pasteur, Johnson and Johnson., Pfizer, GlaxoSmithKline plc, Wantai BioPharm, Serum Institute, Profectus BioSciences, Inc. and Merck & Co., Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global HPV Therapeutic Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The HPV Therapeutic Vaccines market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global HPV Therapeutic Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to HPV Therapeutic Vaccines.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global HPV Therapeutic Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
HPV Therapeutic Vaccines Market by Company
Shanghai Bovax Biotechnology Co., Ltd.
Sanofi Pasteur
Johnson and Johnson.
Pfizer
GlaxoSmithKline plc
Wantai BioPharm
Serum Institute
Profectus BioSciences, Inc.
Merck & Co., Inc
ISA Pharmaceuticals
INOVIO Pharmaceuticals
Emergent BioSolutions
Astellas Pharma
2A Pharma AB
HPV Therapeutic Vaccines Segment by Type
Bivalent HPV vaccine
Quadrivalent HPV vaccine
HPV Therapeutic Vaccines Segment by Application
Man
Woman
HPV Therapeutic Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HPV Therapeutic Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of HPV Therapeutic Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HPV Therapeutic Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of HPV Therapeutic Vaccines companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Bivalent HPV vaccine
- Quadrivalent HPV vaccine
Applications
- Man
- Woman
Companies covered
- Shanghai Bovax Biotechnology Co., Ltd.
- Sanofi Pasteur
- Johnson and Johnson.
- Pfizer
- GlaxoSmithKline plc
- Wantai BioPharm
- Serum Institute
- Profectus BioSciences, Inc.
- Merck & Co., Inc
- ISA Pharmaceuticals
- INOVIO Pharmaceuticals
- Emergent BioSolutions
- Astellas Pharma
- 2A Pharma AB
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global HPV Therapeutic Vaccines Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global HPV Therapeutic Vaccines Market Size by Region (2021-2032)
- 1.4.1 Global HPV Therapeutic Vaccines Market Size by Region (2021-2026)
- 1.4.2 Global HPV Therapeutic Vaccines Market Size by Region (2027-2032)
- 1.5 Key Regions HPV Therapeutic Vaccines Market Size (2021-2032)
- 1.5.1 North America HPV Therapeutic Vaccines Market Size Growth Rate (2021-2032)
- 1.5.2 Europe HPV Therapeutic Vaccines Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific HPV Therapeutic Vaccines Market Size Growth Rate (2021-2032)
- 1.5.4 South America HPV Therapeutic Vaccines Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa HPV Therapeutic Vaccines Market Size Growth Rate (2021-2032)
2 HPV Therapeutic Vaccines Market by Type
- 2.1 Type Introduction
- 2.1.1 Bivalent HPV vaccine
- 2.1.2 Quadrivalent HPV vaccine
- 2.2 Global HPV Therapeutic Vaccines Market Size by Type
- 2.2.1 Global HPV Therapeutic Vaccines Market Size Overview by Type (2021-2032)
- 2.2.2 Global HPV Therapeutic Vaccines Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global HPV Therapeutic Vaccines Market Size Forecasted by Type (2027-2032)
- 2.3 Global HPV Therapeutic Vaccines Market Size by Regions
- 2.3.1 North America HPV Therapeutic Vaccines Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe HPV Therapeutic Vaccines Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific HPV Therapeutic Vaccines Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America HPV Therapeutic Vaccines Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa HPV Therapeutic Vaccines Market Size Breakdown by Type (2021-2026)
3 HPV Therapeutic Vaccines Market by Application
- 3.1 Type Introduction
- 3.1.1 Man
- 3.1.2 Woman
- 3.2 Global HPV Therapeutic Vaccines Market Size by Application
- 3.2.1 Global HPV Therapeutic Vaccines Market Size Overview by Application (2021-2032)
- 3.2.2 Global HPV Therapeutic Vaccines Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global HPV Therapeutic Vaccines Market Size Forecasted by Application (2027-2032)
- 3.3 Global HPV Therapeutic Vaccines Market Size by Regions
- 3.3.1 North America HPV Therapeutic Vaccines Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe HPV Therapeutic Vaccines Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific HPV Therapeutic Vaccines Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America HPV Therapeutic Vaccines Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa HPV Therapeutic Vaccines Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 HPV Therapeutic Vaccines Industry Trends
- 4.2 HPV Therapeutic Vaccines Industry Drivers
- 4.3 HPV Therapeutic Vaccines Industry Opportunities and Challenges
- 4.4 HPV Therapeutic Vaccines Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by HPV Therapeutic Vaccines Revenue (2021-2026)
- 5.2 Global HPV Therapeutic Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global HPV Therapeutic Vaccines Key Company Headquarters & Area Served
- 5.4 Global HPV Therapeutic Vaccines Company, Product Type & Application
- 5.5 Global HPV Therapeutic Vaccines Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global HPV Therapeutic Vaccines Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 HPV Therapeutic Vaccines Players Market Share by Revenue in 2025
- 5.6.3 2025 HPV Therapeutic Vaccines Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Shanghai Bovax Biotechnology Co., Ltd.
- 6.1.1 Shanghai Bovax Biotechnology Co., Ltd. Company Information
- 6.1.2 Shanghai Bovax Biotechnology Co., Ltd. Business Overview
- 6.1.3 Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Product Portfolio
- 6.1.5 Shanghai Bovax Biotechnology Co., Ltd. Recent Developments
- 6.2 Sanofi Pasteur
- 6.2.1 Sanofi Pasteur Company Information
- 6.2.2 Sanofi Pasteur Business Overview
- 6.2.3 Sanofi Pasteur HPV Therapeutic Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Sanofi Pasteur HPV Therapeutic Vaccines Product Portfolio
- 6.2.5 Sanofi Pasteur Recent Developments
- 6.3 Johnson and Johnson.
- 6.3.1 Johnson and Johnson. Company Information
- 6.3.2 Johnson and Johnson. Business Overview
- 6.3.3 Johnson and Johnson. HPV Therapeutic Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Johnson and Johnson. HPV Therapeutic Vaccines Product Portfolio
- 6.3.5 Johnson and Johnson. Recent Developments
- 6.4 Pfizer
- 6.4.1 Pfizer Company Information
- 6.4.2 Pfizer Business Overview
- 6.4.3 Pfizer HPV Therapeutic Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Pfizer HPV Therapeutic Vaccines Product Portfolio
- 6.4.5 Pfizer Recent Developments
- 6.5 GlaxoSmithKline plc
- 6.5.1 GlaxoSmithKline plc Company Information
- 6.5.2 GlaxoSmithKline plc Business Overview
- 6.5.3 GlaxoSmithKline plc HPV Therapeutic Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 GlaxoSmithKline plc HPV Therapeutic Vaccines Product Portfolio
- 6.5.5 GlaxoSmithKline plc Recent Developments
- 6.6 Wantai BioPharm
- 6.6.1 Wantai BioPharm Company Information
- 6.6.2 Wantai BioPharm Business Overview
- 6.6.3 Wantai BioPharm HPV Therapeutic Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Wantai BioPharm HPV Therapeutic Vaccines Product Portfolio
- 6.6.5 Wantai BioPharm Recent Developments
- 6.7 Serum Institute
- 6.7.1 Serum Institute Company Information
- 6.7.2 Serum Institute Business Overview
- 6.7.3 Serum Institute HPV Therapeutic Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Serum Institute HPV Therapeutic Vaccines Product Portfolio
- 6.7.5 Serum Institute Recent Developments
- 6.8 Profectus BioSciences, Inc.
- 6.8.1 Profectus BioSciences, Inc. Company Information
- 6.8.2 Profectus BioSciences, Inc. Business Overview
- 6.8.3 Profectus BioSciences, Inc. HPV Therapeutic Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Profectus BioSciences, Inc. HPV Therapeutic Vaccines Product Portfolio
- 6.8.5 Profectus BioSciences, Inc. Recent Developments
- 6.9 Merck & Co., Inc
- 6.9.1 Merck & Co., Inc Company Information
- 6.9.2 Merck & Co., Inc Business Overview
- 6.9.3 Merck & Co., Inc HPV Therapeutic Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Merck & Co., Inc HPV Therapeutic Vaccines Product Portfolio
- 6.9.5 Merck & Co., Inc Recent Developments
- 6.10 ISA Pharmaceuticals
- 6.10.1 ISA Pharmaceuticals Company Information
- 6.10.2 ISA Pharmaceuticals Business Overview
- 6.10.3 ISA Pharmaceuticals HPV Therapeutic Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 ISA Pharmaceuticals HPV Therapeutic Vaccines Product Portfolio
- 6.10.5 ISA Pharmaceuticals Recent Developments
- 6.11 INOVIO Pharmaceuticals
- 6.11.1 INOVIO Pharmaceuticals Company Information
- 6.11.2 INOVIO Pharmaceuticals Business Overview
- 6.11.3 INOVIO Pharmaceuticals HPV Therapeutic Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 INOVIO Pharmaceuticals HPV Therapeutic Vaccines Product Portfolio
- 6.11.5 INOVIO Pharmaceuticals Recent Developments
- 6.12 Emergent BioSolutions
- 6.12.1 Emergent BioSolutions Company Information
- 6.12.2 Emergent BioSolutions Business Overview
- 6.12.3 Emergent BioSolutions HPV Therapeutic Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Emergent BioSolutions HPV Therapeutic Vaccines Product Portfolio
- 6.12.5 Emergent BioSolutions Recent Developments
- 6.13 Astellas Pharma
- 6.13.1 Astellas Pharma Company Information
- 6.13.2 Astellas Pharma Business Overview
- 6.13.3 Astellas Pharma HPV Therapeutic Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Astellas Pharma HPV Therapeutic Vaccines Product Portfolio
- 6.13.5 Astellas Pharma Recent Developments
- 6.14 2A Pharma AB
- 6.14.1 2A Pharma AB Company Information
- 6.14.2 2A Pharma AB Business Overview
- 6.14.3 2A Pharma AB HPV Therapeutic Vaccines Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 2A Pharma AB HPV Therapeutic Vaccines Product Portfolio
- 6.14.5 2A Pharma AB Recent Developments
7 North America
- 7.1 North America HPV Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America HPV Therapeutic Vaccines Market Size by Country (2021-2026)
- 7.3 North America HPV Therapeutic Vaccines Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe HPV Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe HPV Therapeutic Vaccines Market Size by Country (2021-2026)
- 8.3 Europe HPV Therapeutic Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific HPV Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific HPV Therapeutic Vaccines Market Size by Country (2021-2026)
- 9.3 Asia-Pacific HPV Therapeutic Vaccines Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America HPV Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America HPV Therapeutic Vaccines Market Size by Country (2021-2026)
- 10.3 South America HPV Therapeutic Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa HPV Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa HPV Therapeutic Vaccines Market Size by Country (2021-2026)
- 11.3 Middle East & Africa HPV Therapeutic Vaccines Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst